Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAWYER, JENNIFER C | 1 | 68.7% | -9.1% |
| HILL, MYRON G | 1 | 66.3% | +20.1% |
| LEE, WILLIAM Y | 1 | 48.2% | +34.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568769 | COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE | HILL, MYRON G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568769 | COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE | HILL, MYRON G | — |
| 18279577 | ENDOXIFEN FOR TREATMENT OF OVARIAN CANCER | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 1671 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19005858 | ANTI-TUMOR COMPOUNDS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOF | SAWYER, JENNIFER C | 1691 | §103 | Non-Final OA | 28d | Pending | Dec 30, 2024 |
| 18568769 | COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE | HILL, MYRON G | 1671 | §102§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18279577 | ENDOXIFEN FOR TREATMENT OF OVARIAN CANCER | LEE, WILLIAM Y | 1623 | §103 | Non-Final OA | — | Pending | Aug 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial